Clinical Trial: Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Tazemetostat Rollover Study (TRuST): An Open-Label Rollover Study

Brief Summary: This study will provide continuing availability to tazemetostat as a single agent to subjects who have completed their participation in an antecedent tazemetostat study (either with monotherapy or combination therapy). In addition, long-term safety and overall survival will be collected.